TheraCryf (LSE:TCF) OCF Margin %: 0.00% (As of Sep. 2025)


What is TheraCryf OCF Margin %?

TheraCryf LSE:TCF OCF Margin % is 0.00% as of Sep. 2025. The stock has 4 warning signs investors should review. Among 960 Biotechnology companies, TheraCryf ranks worse than 104166.56% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. TheraCryf's Cash Flow from Operations for the six months ended in Sep. 2025 was £-0.72 Mil. TheraCryf's Revenue for the six months ended in Sep. 2025 was £0.00 Mil. Therefore, TheraCryf's OCF Margin % for the quarter that ended in Sep. 2025 was 0.00%.

As of today, TheraCryf's current OCF Yield % is -33.64%.

The historical rank and industry rank for TheraCryf's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of TheraCryf was -756.57%. The lowest was -1508.25%. And the median was -933.71%.

LSE:TCF's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

TheraCryf OCF Margin % Related Terms

TheraCryf OCF Margin % Historical Data

* Premium members only.

The historical data trend for TheraCryf's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TheraCryf OCF Margin % Chart

TheraCryf Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,508.25 0.00 -933.71 -756.57 0.00

TheraCryf Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -321.21 0.00 0.00 0.00 0.00

TheraCryf OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

TheraCryf's OCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-2.367/0
= %

TheraCryf's OCF Margin for the quarter that ended in Sep. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-0.721/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
TheraCryf (LSE:TCF) has a OCF Margin % of 0.00% as of Sep. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TheraCryf and its competitors. According to the industry distribution chart, TheraCryf ranks #999999 out of 960 companies in the Biotechnology industry.
Is TheraCryf's OCF Margin % too high?
TheraCryf's current OCF Margin % is 0.00%. Based on the distribution chart, TheraCryf ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does TheraCryf's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TheraCryf ranks #999999 out of 960 companies for OCF Margin %. This places TheraCryf in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TheraCryf and its competitors. TheraCryf's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TheraCryf stock overvalued right now?
TheraCryf (LSE:TCF) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For TheraCryf (LSE:TCF), the current OCF Margin % is 0.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TheraCryf Business Description

Address Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
TheraCryf PLC is a clinical stage therapeutics company developing therapeutic candidates for behavioural brain disorders such as opioid and alcohol addiction, and acute/chronic fatigue. It focuses on data generation to support potential partnerships for its programs with mid-sized and large pharmaceutical companies. The company's pipeline includes Ox-1 - Substance Use Disorders (SUDs) / Anxiety, DAT - Fatigue and Narcolepsy, SFX-01, and SFX-01- Neurodevelopmental Disorders.